Month: September 2020

Companies are quickly filling the demand for more rapid COVID-19-related diagnostics. BD is the latest firm to do so with the availability of its point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor Plus System in Europe. The Franklin, Lakes, NJ-based firm said the new test delivers results in less than 15 minutes and
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 30 2020 Recreational use of the illicit drug methamphetamine has long been associated with increases in overall impatient and risky behavior. Now, a new study by Johns Hopkins Medicine researchers affirms that meth use increases not only sexual desire but also, specifically and measurably, the risk of casual sex without
0 Comments
Some may ask the question, “What does a care coordinator do for my personal well-being?” There is no short answer as to what a patient can benefit from by receiving assistance from a care coordinator. Their job is to connect with high-risk individuals to uncover and identify needs in a patient-centered manner and in a
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 30 2020 Scripps Research chemist Matthew Disney, PhD, and colleagues have created drug-like compounds that, in human cell studies, bind and destroy the pandemic coronavirus’ so-called “frameshifting element” to stop the virus from replicating. The frameshifter is a clutch-like device the virus needs to generate new copies of itself after
0 Comments
Video highlights of COVID-19 data trends as of September 30, 2020. This daily report shares critical data on the spread of COVID-19 over the last 24 hours. For the latest news, trends, and expert insights on the coronavirus pandemic, visit the JHU Coronavirus Resource Center: https://coronavirus.jhu.edu/ Explore COVID-19 trends around the world with our in-depth
0 Comments
Wireless devices are already transforming self-care for the consumers who wear them. But can wearable medical devices impact patient outcomes? Jeanette Numbers, co-founder and principal for Loft, sees such potential, but only if wearables can do more than just monitor and report patient data.  Numbers has focused on creating visually compelling, human-centered design solutions described
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 30 2020 A team of researchers led by biomedical scientist Declan F. McCole at the University of California, Riverside, has found that the drug tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can repair permeability defects in the intestine. Our work could
0 Comments
With evolving news headlines about COVID-19, the mention of supply-chain shortages in the medical industry brings to mind surgical masks, protective equipment, and virus test kits. Yet since this time last year, there also have been headlines about supply-chain risks of another kind—those related to temporary or permanent closures of ethylene oxide (EtO) sterilization facilities. Several
0 Comments
One company’s challenge is another company’s opportunity. Integra LifeSciences is hoping to offload its extremity orthopedic business to Smith & Nephew for $240 million in cash. The sale is expected to close around the end of the year and includes Integra’s upper and lower extremity orthopedics product portfolio, including ankle and shoulder arthroplasty, and hand and wrist
0 Comments
Video highlights of COVID-19 data trends as of September 29, 2020. This daily report shares critical data on the spread of COVID-19 over the last 24 hours. For the latest news, trends, and expert insights on the coronavirus pandemic, visit the JHU Coronavirus Resource Center: https://coronavirus.jhu.edu/ Explore COVID-19 trends around the world with our in-depth
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 29 2020 Loved or hated, the humble oat could be the new superfood for cancer patients as international research shows a diet rich in fiber could significantly reduce radiation-induced gut inflammation. Conducted by the University of Gothenburg, Lund University and the University of South Australia, the preclinical study found that
0 Comments